Dosing & Uses
Macular Degeneration
Pending FDA approval of neovascular (wet) age-related macular degeneration (AMD)
Next:
Pharmacology
Mechanism of Action
Binds and prevents activation of vascular endothelial growth factors (VEGF-A) and placental growth factor (PIGF)
Activation of VEGF-A and PIGF can result in neovascularization and vascular permeability
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.